Clinical Trials
11 trialsNCT03081858 2025-06-27
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Lipac Oncology LLC
Phase 1/2 Completed
NCT04005183 2024-10-10
REMEDY
University Health Network, Toronto
Completed
NCT02301117 2024-09-05
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Taiho Oncology, Inc.
Phase 1 Completed
NCT04594161 2024-02-28
STONE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT04555343 2021-11-05
Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention
Fraser Health
Phase 1/2 Completed
NCT01339975 2019-08-05
ChemoRenCan
University Hospital, Bordeaux
Completed
NCT03010813 2018-02-06
A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
Chinese University of Hong Kong
Phase NA Completed
NCT01803295 2017-06-16
OPTIMA
UroGen Pharma Ltd.
Phase NA Completed
NCT02307487 2017-06-16
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients
UroGen Pharma Ltd.
Phase 2 Completed
NCT02891460 2016-09-08
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients
UroGen Pharma Ltd.
Phase NA Completed
NCT00753415 2015-03-17
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Phase 1 Completed